UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008599
Receipt number R000010103
Scientific Title Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study
Date of disclosure of the study information 2012/08/06
Last modified on 2013/04/12 09:43:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study

Acronym

Preferences for pharmacists' provision of information in patients with breast cancer

Scientific Title

Preferences for pharmacists' provision of information in patients with breast cancer: Discrete Choice Experiments, Cross-sectional Study

Scientific Title:Acronym

Preferences for pharmacists' provision of information in patients with breast cancer

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To explore patients' preferences for pharmacists's provsion of information among patients with breast cancer.

Basic objectives2

Others

Basic objectives -Others

Tendency of patients' preference

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Patients' preference

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. 20 years and older
2. Diagnosed as breast cancer
3. Outpatients have previously received or is currently receiving chemothera

Key exclusion criteria

1. ECOG PS 3-4
2. Cognitive disorder, agitation or delirium
3. Severe psychiatric disorder
4. Patients judged inappropriate for this study by the health care provider

Target sample size

280


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Akashi

Organization

Tokyo Medical University Hospital

Division name

Department of Pharmacy

Zip code


Address

160-0022, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Takashi Kawaguchi

Organization

Tokyo University of Pharmacy and Life Sciences

Division name

Department of Practical Pharmacy

Zip code


Address

192-0392, 1432-1 Horinouchi, Hachioji, Tokyo, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Tokyo University of Pharmacy and Life Sciences
Department of Practical Pharamcy

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University Hospital
Department of Pharamcy

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Nagumo Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学病院(東京都)、ナグモクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Two types of questionnaire were randomly assigned to patients. Patients were asked to complete the questionnaire based discrete choice experiments one time.


Management information

Registered date

2012 Year 08 Month 02 Day

Last modified on

2013 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010103


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name